We could not find any results for:
Make sure your spelling is correct or try broadening your search.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics.
TEL AVIV, Israel, April 18, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical-stage specialty pharmaceutical company focused on the...
TEL AVIV, Israel, April 16, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical-stage specialty pharmaceutical company focused on the...
TEL AVIV, Israel, April 09, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the...
TEL AVIV, Israel, April 02, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the...
Reports continued enrollment in the second part of the Phase 3 clinical trial in bunionectomy Remains on track to announce top-line data by mid-2024 TEL AVIV, Israel, March 01, 2024 (GLOBE...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0198 | -2.2633744856 | 0.8748 | 0.9696 | 0.75 | 28522 | 0.85835108 | CS |
4 | -1.115 | -56.5989847716 | 1.97 | 2.55 | 0.69 | 412406 | 1.39769998 | CS |
12 | -1.265 | -59.6698113208 | 2.12 | 2.55 | 0.69 | 153633 | 1.44165099 | CS |
26 | -1.655 | -65.9362549801 | 2.51 | 3.36 | 0.69 | 85714 | 1.6132802 | CS |
52 | -6.046 | -87.6104912332 | 6.901 | 26.41 | 0.69 | 396263 | 8.40202135 | CS |
156 | -25.945 | -96.8097014925 | 26.8 | 78.4 | 0.69 | 365429 | 21.07664944 | CS |
260 | -65.845 | -98.7181409295 | 66.7 | 78.4 | 0.69 | 329221 | 23.97900934 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions